Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AEZS

Aeterna Zentaris (AEZS)

Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AEZS
DateTimeSourceHeadlineSymbolCompany
09/03/20157:30AMPR Newswire (Canada)Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New YorkNASDAQ:AEZSAeterna Zentaris Inc
09/03/20157:30AMPR Newswire (Canada)Aeterna Zentaris fera une présentation à la Rodman & Renshaw Annual Global Investment Conference à New YorkNASDAQ:AEZSAeterna Zentaris Inc
08/13/20154:39PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
08/13/20154:38PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:AEZSAeterna Zentaris Inc
08/13/20154:15PMPR Newswire (Canada)Aeterna Zentaris Reports Second Quarter Financial and Operating ResultsNASDAQ:AEZSAeterna Zentaris Inc
08/13/20154:15PMPR Newswire (US)Aeterna Zentaris Reports Second Quarter Financial and Operating ResultsNASDAQ:AEZSAeterna Zentaris Inc
08/13/20154:15PMPR Newswire (Canada)Aeterna Zentaris annonce ses résultats financiers et d'exploitation du second trimestre 2015NASDAQ:AEZSAeterna Zentaris Inc
08/11/20157:30AMPR Newswire (Canada)Aeterna Zentaris Announces Data and Safety Monitoring Board Scheduled to Complete Second Interim Analysis of the ZoptEC Phase...NASDAQ:AEZSAeterna Zentaris Inc
08/11/20157:30AMPR Newswire (US)Aeterna Zentaris Announces Data and Safety Monitoring Board Scheduled to Complete Second Interim Analysis of the ZoptEC Phase...NASDAQ:AEZSAeterna Zentaris Inc
08/11/20157:30AMPR Newswire (Canada)Aeterna Zentaris : 2e analyse intérimaire de l'étude ZoptEC de Phase 3 sur le cancer de l'endomètre par un comité indépe...NASDAQ:AEZSAeterna Zentaris Inc
08/06/20157:30AMPR Newswire (Canada)Aeterna Zentaris to Announce Second Quarter 2015 Financial and Operating Results on August 13, 2015NASDAQ:AEZSAeterna Zentaris Inc
08/06/20157:30AMPR Newswire (US)Aeterna Zentaris to Announce Second Quarter 2015 Financial and Operating Results on August 13, 2015NASDAQ:AEZSAeterna Zentaris Inc
08/06/20157:30AMPR Newswire (Canada)Aeterna Zentaris dévoilera ses résultats financiers et d'exploitation du 2ième trimestre 2015, le 13 août 2015NASDAQ:AEZSAeterna Zentaris Inc
08/04/20157:30AMPR Newswire (Canada)Aeterna Zentaris to Present at Upcoming Canaccord Genuity 35th Annual Global Growth Conference in BostonNASDAQ:AEZSAeterna Zentaris Inc
08/04/20157:30AMPR Newswire (US)Aeterna Zentaris to Present at Upcoming Canaccord Genuity 35th Annual Global Growth Conference in BostonNASDAQ:AEZSAeterna Zentaris Inc
08/04/20157:30AMPR Newswire (Canada)Aeterna Zentaris fera une présentation à la Canaccord Genuity 35th Annual Global Growth Conference à BostonNASDAQ:AEZSAeterna Zentaris Inc
07/29/20157:30AMPR Newswire (Canada)Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further DevelopmentNASDAQ:AEZSAeterna Zentaris Inc
07/29/20157:30AMPR Newswire (US)Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further DevelopmentNASDAQ:AEZSAeterna Zentaris Inc
07/29/20157:30AMPR Newswire (Canada)Aeterna Zentaris annonce l'optimisation de composés inhibiteurs d'Erk pour du développement futurNASDAQ:AEZSAeterna Zentaris Inc
07/28/20157:30AMPR Newswire (Canada)Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine TechnologyNASDAQ:AEZSAeterna Zentaris Inc
07/28/20157:30AMPR Newswire (US)Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine TechnologyNASDAQ:AEZSAeterna Zentaris Inc
07/28/20157:30AMPR Newswire (Canada)Aeterna Zentaris accorde une option pour développer et commercialiser la technologie de vaccination allogénique orale contr...NASDAQ:AEZSAeterna Zentaris Inc
07/27/20157:30AMPR Newswire (Canada)Aeterna Zentaris entame les activités de promotion du produit Saizen(MD) [somatropine (origine ADNr) pour injection] d'EMD S...NASDAQ:AEZSAeterna Zentaris Inc
07/27/20157:30AMPR Newswire (US)Aeterna Zentaris Commences Promotional Activities for EMD Serono's Saizen® [Somatropin (rDNA origin) for Injection]NASDAQ:AEZSAeterna Zentaris Inc
07/27/20157:30AMPR Newswire (Canada)Aeterna Zentaris Commences Promotional Activities for EMD Serono's Saizen® [Somatropin (rDNA origin) for Injection]NASDAQ:AEZSAeterna Zentaris Inc
07/16/20159:10AMPR Newswire (US)Equity Coverage on Biotechnology -- Aeterna Zentaris, Ariad Pharma, AVEO Pharma, Aduro BioTech, and 22nd Century GroupNASDAQ:AEZSAeterna Zentaris Inc
06/30/20157:30AMPR Newswire (Canada)Aeterna Zentaris Completes Patient Recruitment for ZoptEC Phase 3 Study with Zoptarelin Doxorubicin in Advanced Endometrial C...NASDAQ:AEZSAeterna Zentaris Inc
06/30/20157:30AMPR Newswire (US)Aeterna Zentaris Completes Patient Recruitment for ZoptEC Phase 3 Study with Zoptarelin Doxorubicin in Advanced Endometrial C...NASDAQ:AEZSAeterna Zentaris Inc
06/30/20157:30AMPR Newswire (Canada)Aeterna Zentaris a complété le recrutement de patientes pour l'étude ZoptEC de Phase 3 sur le cancer avancé de l'endomèt...NASDAQ:AEZSAeterna Zentaris Inc
06/25/20157:30AMPR Newswire (Canada)Aeterna Zentaris choisit Ergomed pour mener l'étude clinique confirmatoire de phase 3 sur la DHCA avec Macrilen(MC)NASDAQ:AEZSAeterna Zentaris Inc
 Showing the most relevant articles for your search:NASDAQ:AEZS